Overview

Observational Study of Meloxicam in Any Labeled Indication

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Meloxicam